Astrazenaca

AstraZeneca Pharma India Ltd.'s stock jumped nearly 10 per cent, a day after the company's board declared dividend of Rs 8 per share.

The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening

US drug major Pfizer today shelved its $117-billion takeover bid of AstraZenaca on the day of expiry of the offer as the British pharmaceutical company remained firm in opposing the deal.

Astrazenaca Pharma India has surged 47 per cent in the past 4 trading sessions on expectation that the delisting price would be at a substantial premium to the existing market price of the company.

AstraZeneca Pharma India Ltd.'s stock jumped nearly 10 per cent, a day after the company's board declared dividend of Rs 8 per share.

The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening

US drug major Pfizer today shelved its $117-billion takeover bid of AstraZenaca on the day of expiry of the offer as the British pharmaceutical company remained firm in opposing the deal.

Astrazenaca Pharma India has surged 47 per cent in the past 4 trading sessions on expectation that the delisting price would be at a substantial premium to the existing market price of the company.